Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 17 is an intermediary GPCR involved in nucleotide/leukotriene signaling. It plays critical roles in CNS development/injury response—particularly regulating oligodendrocyte maturation/myelin repair—and represents an emerging therapeutic target for neurodegenerative diseases marked by demyelination or white matter loss.
Inhibition of GPR17 activity via binding of antagonists; Gi/o protein activation leading to inhibition of adenylyl cyclase; Gq protein activation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 17 (GPR17).